A
Aging process, clinical treatment of, 97–104
Alginates, impact of molecular weight on biocompatibility for grafting, 383–394
Amberlite IRA‐938, compared to chitin for α‐galactosidase immobilization, 19–33
Anemia, and vitamin E‐bonded cellulose membrane and lipoperoxidation in hemodialysis patients, 185–191
Arginine selective biosensor, based on arginase‐urease immobilized in gelatin, 357–363
Artificial organs
as a bridge to transplantation, 163–168
and transplantation, 91–96
See also Specific organ
Artificial red blood cells, polyethylene‐glycol‐polylactide nano‐dimension, maintenance of systemic hemoglobin levels and prevention of methemoglobin formation by, 231–247
B
Bioartificial organ grafts, 365–382
Biocompatibility, of alginates for grafting, 383–394
Bionic ear, and deafness, 139–143
Bionic kidney, 105–110
Bone marrow stromal cells, enriched with osteogenic potential, collagen as an immobilization vehicle for, 59–68
Bone tissue engineering scaffold, preparation and characterization of collagen–hydroxyapatite composite for, 435–448
C
Cells isolation, polypropylene hollow fiber for, 249–262
Cephalosporin‐C, continuous production by immobilized microbial cells using symbiotic mode in a packed bed bioreactor, 313–327
Chitin
compared to Amberlite IRA‐938 for α‐galactosidase immobilization, 19–33
preparation and properties of α‐galactosidase chemically attached to, 339–355
Chitosan microcarriers, cross‐linked by oxidized lactose and culture of primary hepatocytes, 293–301
Cholesterol, application of phospholipase A2 immobilization on porous glass for lowering serum concentration of, 467–478
Collagen, as an immobilization vehicle for bone marrow stromal cells enriched with osteogenic potential, 59–68
Collagen–hydroxyapatite composite, for bone tissue engineering scaffold, 435–448
Controlled release, of vincristine sulfate, 81–88
Costimulatory molecules, amplification of T‐cell activation in vector‐based and vector‐infected dendritic cell vaccines by a triad of, 193–228
D
Deafness, and the bionic ear, 139–143
Dendritic cell vaccines, vector based and vector infected, amplification of T‐cell activation by a triad of costimulatory molecules, 193–228
Dialysis, reduced social costs and alleviation of personal suffering in, 179–184
E
Enzyme electrode, based on lipoxygenase immobilized in gelatin for selective determination of essential fatty acids, 329–337
Essential amino acids treatment, effects on osteopenic bone‐derived osteoblasts, 35–46
Essential fatty acids, selective determination by an enzyme electrode based on lipoxygenase immobilized in gelatin, 329–337
Ethanol‐destabilized method, for encapsulation of protein into preformed liposomes, 303–312
F
Flow cytometry, of liposomes and blood cells, 395–424
G
α‐Galactosidase
chemically attached to activated chitin, 339–355
comparison of chitin and α‐galactosidase for immobilization of, 19–33
Gelatin
arginine selective biosensor based on arginase‐urease immobilized in, 357–363
cross‐linked, immobilization of glutathione‐s‐transferase in cylindrical molds of, 47–57
selective determination of essential fatty acids by an enzyme electrode based on lipoxygenase immobilized in, 329–337
Glutathione‐s‐transferase, immobilization within cross‐linked gelatin cylindrical molds, 47–57
Grafting
of bioartificial organs, 365–382
impact of molecular weight of alginate on biocompatibility for, 383–394
H
Heart, artificial, 113–115
Hemodialysis patients, vitamin E‐bonded cellulose membrane, lipoperoxidation, and anemia in, 185–191
Hemodialytic strategies, 169–178
Hemoglobin
bovine, preparation and characterization of monomethoxypoly(ethylene glycol)‐b‐poly‐dl‐lactide microcapsules containing, 279–292
maintenance of levels by polyethylene‐glycol‐polylactide nano‐dimension artificial red blood cells, 231–247
Hemoglobin raffimer (Hemolink), intravascular persistence and methemoglobin formation of, 1–17
Hemolink™ (hemoglobin raffimer), intravascular persistence and methemoglobin formation of, 1–17
Hepatocytes, primary, culture on chitosan microcarriers cross‐linked by oxidized lactose, 293–301
I
Immobilized microbial cells, continuous production of cephalosporin‐C using symbiotic mode in a packed bed bioreactor, 313–327
International Conference on Current Issues in Blood Substitute Research
oral presentations, 479–505
poster presentations, 507–521
Intravascular persistence, of Hemolink, 1–17
K
Kidney
bionic, 105–110
artificial, 111–112
L
Lactobacillus, free and microencapsulated, and effects of metabolic induction on urea removal, 425–434
Lipoperoxidation, and vitamin E‐bonded cellulose membrane and anemia in hemodialysis patients, 185–191
Liposomes
and blood cells, flow cytometry of, 395–424
preformed, ethanol‐destabilized method for encapsulation of protein into, 303–312
Lipoxygenase, immobilized in gelatin, selective determination of essential fatty acids by an enzyme electrode based on, 329–337
Liver, artificial, 117–126
M
Metabolic induction, free and microencapsulated Lactobacillus and effects on urea removal, 425–434
Metabolic organ functions, artificial cells for replacement of, 151–161
Methemoglobin formation
of Hemolink, 1–17
prevention by polyethylene‐glycol‐polylactide nano‐dimension artificial red blood cells, 231–247
Monomethoxypoly(ethylene glycol)‐b‐poly‐dl‐lactide microcapsules, containing bovine hemoglobin, 279–292
Myasthenia gravis, plasmaperfusion on triptophan columns for improvement of the clinical outcome of patients affected with, 69–79
O
Osteoblasts
cultured from osteoporotic bone, comparative investigation of human and animal‐derived cells for, 263–277
osteopenic bone derived, essential amino acids treatment effects on, 35–46
primary, response to shock wave therapy, 449–466
Osteogenic potential, collagen as an immobilization vehicle for bone marrow stromal cells enriched with, 59–68
Osteopenic bone‐derived osteoblasts, essential amino acids treatment effects on, 35–46
Osteoporotic bone, comparative investigation of human and animal‐derived cells for osteoblasts cultured from, 263–277
Oxidized lactose, culture of primary hepatocytes on chitosan microcarriers cross‐linked by, 293–301
P
Packed bed bioreactor, continuous production of cephalosporin‐C by immobilized microbial cells using symbiotic mode in, 313–327
Pancreas, artificial, 127–138
Phospholipase A2, immobilization on porous glass and application for lowering serum cholesterol concentration, 467–478
Plasmaperfusion, on triptophan columns for improvement of the clinical outcome of patients affected with myasthenia gravis, 69–79
Polyethylene‐glycol‐polylactide nano‐dimension artificial red blood cells, maintenance of systemic hemoglobin levels and prevention of methemoglobin formation by, 231–247
Polypropylene hollow fiber, for cells isolation, 249–262
Porous glass, immobilization of phospholipase A2 on and application for lowering serum cholesterol concentration, 467–478
Protein, encapsulation into preformed liposomes by ethanol‐destabilized method, 303–312
Q
Quality treatment, for patient well being, 179–184
S
Shock wave therapy, response of primary osteoblasts to, 449–466
T
T‐cell activation, in vector‐based and vector‐infected dendritic cell vaccines, amplification by a triad of costimulatory molecules, 193–228
Transplantation
artificial kidney, 111–112
artificial heart, 113–115
artificial liver, 117–126
artificial organs as a bridge to, 163–168
and artificial organs, 91–96
artificial pancreas, 127–138
bionic kidney, 105–110
Triptophan columns, improvement of the clinical outcome of patients affected with myasthenia gravis by plasmaperfusion on, 69–79
U
Urea removal, free and microencapsulated Lactobacillus and effects of metabolic induction on, 425–434
V
Vector‐based and vector‐infected dendritic cell vaccines, amplification of T‐cell activation by a triad of costimulatory molecules, 193–228
Vincristine sulfate, controlled release of, 81–88
Vitamin E‐bonded cellulose membrane, and lipoperoxidation and anemia in hemodialysis patients, 185–191
X
Xenotransplantation, 145–148